Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Humanised monoclonal antibody targeting interleukin-15

EU orphan designation number: EU/3/16/1681   
Active ingredient: Humanised monoclonal antibody targeting interleukin-15
Indication: Treatment of eosinophilic oesophagitis
Sponsor: Dr Alain Vicari
32, La Ruelle, 74160 Neydens, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/06/2016 Orphan designation EMA/OD/004/16 (2016)4122 of 27/06/2016